Toggle light / dark theme

Scientists create world’s first ‘molecular robot’ capable of building molecules

Scientists at The University of Manchester have created the world’s first ‘molecular robot’ that is capable of performing basic tasks including building other molecules. The tiny robots, which are a millionth of a millimetre in size, can be programmed to move and build molecular cargo, using a tiny robotic arm.

Each individual robot is capable of manipulating a single molecule and is made up of just 150 carbon, hydrogen, oxygen and nitrogen atoms. To put that size into context, a billion billion of these robots piled on top of each other would still only be the same size as a single grain of salt. The robots operate by carrying out chemical reactions in special solutions which can then be controlled and programmed by scientists to perform the basic tasks.

In the future such robots could be used for medical purposes, advanced manufacturing processes and even building molecular factories and assembly lines. The research will be published in Nature on Thursday 21st September.

Rise of the Robolawyers

Thankfully, no one’s out there systematically murdering lawyers. But advances in artificial intelligence may diminish their role in the legal system or even, in some cases, replace them altogether. Here’s what we stand to gain—and what we should fear—from these technologies.


How legal representation could come to resemble TurboTax.

Chinese robot dentist is first to fit implants in patient’s mouth without any human involvement

An epidemiological survey has found there were about 400 million patients needing new teeth in China, but the number of qualified dentists was lagging behind demand.

In March this year the US Food and Drug Administration approved the use of a robot system named Yomi designed to assist human surgeons when fitting implants.


Successful procedure raises hopes technology could avoid problems caused by human error and help overcome shortage of qualified dentists.

PUBLISHED : Thursday, 21 September, 2017, 6:30pm.

UPDATED : Friday, 22 September, 2017, 9:43pm.

Four Ways We Can “Swallow the Doctor”

Summary: Nanodocs? #Swallow #the #doctor? The authors of a recent research study, says soon we will be able to “swallow the surgeon.” Using medical #nanobots to diagnose and treat disease from inside the body. Study authors documented recent advances in nanotechnology tools, such as nanodrillers, microgrippers, and microbullets – and show how #nanodocs have tremendous potential in the areas of precision surgery, detection, detoxification and targeted drug delivery.


Summary: Nanodocs? Swallow the doctor? The authors of a recent research study, say the concept of “swallow the surgeon” – or using medical nanobots to diagnose and treat disease from inside the body – may be closer than we think. Study authors document recent advances in nanotechnology tools, such as nanodrillers, microgrippers, and microbullets – and show how nanodocs have tremendous potential in the areas of precision surgery, detection, detoxification and targeted drug delivery. Cover photo: The old way to swallow the surgeon. Credit: R. Collin Johnson / Attributed to Stanford University.

Imagine that you need to repair a defective heart valve, a major surgery. Instead of ripping your chest cut open, a doctor merely injects you with a syringe full of medical nanorobots, called nanodocs for short. You emerge from the ‘surgery’ unscathed, and your only external wound is the puncture hole from the injection.

According to a recent study published by nanorobotic engineers at the University of California San Diego (UCSD), the concept of ‘swallow the doctor’ may be closer to reality than we think.

How AI can Help Reduce the Cost of Drug Discovery

The cost of drug discovery and subsequent development is a massive challenge in the pharmaceutical industry. A typical drug can cost upwards of $2.5 billion and a decade or more to identify and test a new drug candidate[1].

These costs have been increasing steadily over the years, and pharmaceutical manufacturers are constantly seeking ways to improve efficiency to save time and money and speed up research progress.

Automation in the lab is one example; tasks that were traditionally carried out by technicians can now be done by machines. Increasingly sophisticated assays to detect new drug candidates have also helped to slash development time. Now a new ally has arrived to aid drug development – artificial intelligence – and a powerful ally it is.

I Tried Direct Neurofeedback and the Results Surprised Me

My new story for my #transhumanism column at Psychology Today on Direct Neurofeedback:


Transhumanism—the movement of using science and technology to improve the human being—covers many different fields of research. There are exoskeleton suits to help the disabled; there are stem cell treatments to cure disease; there are robots and AI to perform human chores. The field is wide open and booming as humanity uses more and more tech in its world.

It’s not that often I get to participate directly in these radical technologies, but I did so recently when Grant Rudolph, Clinical Director at Echo Rock Neurotherapy in Mill Valley, California invited me to try his Direct Neurofeedback techniques. Via his computer and EEG wire hookups, Mr. Rudolph echoed my brainwave information back into my head at an imperceptible level. I did two sessions of Direct Neurofeedback.

At first, I was skeptical that I’d even feel anything since the EEG information can’t be detected by the skin as a sensation, but within five minutes of having the wires stuck onto my forehead, I began feeling different. I can compare it to a light dose of a recreational drug: I felt happy, content, and worry-free. I also felt more introspective than normal. The feedback only took a few seconds, and after about 15 minutes, I seemed to notice the world’s colors were sharper and my hearing was more acute. The heightened awareness and calming effect lasted about 24 hours and then most of it gradually wore off. Some of the clarity must still be working, because getting things done sometimes still seems easier. I’m told that continued sessions would make this state of clarity my new norm.

Zoltan Istvan

Hospital Captures First Commercial Volta GPU Based DGX-1 Systems

At well over $150,000 per appliance, the Volta GPU based DGX appliances from Nvidia, which take aim at deep learning with framework integration and 8 Volta-accelerated nodes linked with NVlink, is set to appeal to the most bleeding edge of machine learning shops.

Nvidia has built its own clusters by stringing several of these together, just as researchers at Tokyo Tech have done with the Pascal generation systems. But one of the first commercial customers for the Volta based boxes is the Center for Clinical Data Science, which is part of the first wave of hospitals set to use deep learning for MR and CT image analysis.

The center, which is based in Cambridge, Massachusetts, has secured a whopping four DGX-1 Volta appliances, which sport the latest GPUs with eight per node with the NVlink interconnect. The Next Platform talked with Neil Tenenholtz, senior data scientist at the center, about where deep learning will yield results for hospitals and medical research and about their early experiences with the four machines.

/* */